Literature DB >> 17632713

Imaging of corticobasal degeneration syndrome.

Masamichi Koyama1, Akira Yagishita, Yasuhiro Nakata, Masaharu Hayashi, Mitsuaki Bandoh, Toshio Mizutani.   

Abstract

INTRODUCTION: Diagnosing corticobasal degeneration is often difficult on the basis of clinical symptoms and radiological images. We aimed to clarify the imaging findings of corticobasal degeneration syndrome (CBDS).
METHODS: Included in the study were 16 patients (8 men, 8 women, 46-75 years old) with clinically diagnosed CBDS. We evaluated the patients' symptoms and signs, and MR and single-photon emission CT (SPECT) imaging findings.
RESULTS: All the patients had cerebral atrophy. Asymmetric cerebral atrophy was observed in 13 patients (81%) predominantly contralateral to the side clinically more affected. Atrophy in the cerebral peduncle was observed in seven patients. FLAIR images showed hyperintensity in the subcortical white matter in the frontoparietal lobes in the clinically more affected side in 14 patients, and in the rolandic region in 13 patients. Asymmetric hypoperfusion in the frontoparietal lobes on SPECT images was observed in all of the patients, and in the basal ganglia in 11 patients.
CONCLUSION: CBDS might be unique in showing hyperintensity in the subcortical white matter in the rolandic region on FLAIR images with asymmetric atrophy predominantly contralateral to the side clinically more severely affected. Asymmetric atrophy in the cerebral peduncle without signal abnormalities was also characteristic of CBDS. Atrophy in the midbrain tegmentum was also seen in patients with CBDS.

Entities:  

Mesh:

Year:  2007        PMID: 17632713     DOI: 10.1007/s00234-007-0265-6

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  16 in total

1.  Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.

Authors:  C J Galton; K Patterson; J H Xuereb; J R Hodges
Journal:  Brain       Date:  2000-03       Impact factor: 13.501

2.  White matter hyperintensities on MRI in a patient with corticobasal degeneration.

Authors:  T Doi; K Iwasa; T Makifuchi; M Takamori
Journal:  Acta Neurol Scand       Date:  1999-03       Impact factor: 3.209

3.  Corticospinal tract atrophy in corticobasal degeneration.

Authors:  Kai Boelmans; Jörn Kaufmann; Nils Bodammer; Hans-Jochen Heinze; Ludwig Niehaus
Journal:  Arch Neurol       Date:  2006-03

Review 4.  Constant and severe involvement of Betz cells in corticobasal degeneration is not consistent with pyramidal signs: a clinicopathological study of ten autopsy cases.

Authors:  Kuniaki Tsuchiya; Shigeo Murayama; Kazuko Mitani; Tatsuro Oda; Kunimasa Arima; Masaru Mimura; Hiroshi Nagura; Chie Haga; Haruhiko Akiyama; Hiroshi Yamanouchi; Hidehiro Mizusawa
Journal:  Acta Neuropathol       Date:  2005-02-25       Impact factor: 17.088

5.  Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations.

Authors:  Eiji Matsusue; Toshibumi Kinoshita; Eisaku Ohama; Toshihide Ogawa
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

Review 6.  Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia.

Authors:  Bradley F Boeve; Anthony E Lang; Irene Litvan
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

7.  Progressive supranuclear palsy: MRI and pathological findings.

Authors:  A Yagishita; M Oda
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

8.  Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging.

Authors:  H Oba; T Araki; K Ohtomo; S Monzawa; G Uchiyama; K Koizumi; Y Nogata; K Kachi; Z Shiozawa; M Kobayashi
Journal:  Radiology       Date:  1993-12       Impact factor: 11.105

9.  Alzheimer's disease with asymmetric atrophy of the cerebral hemispheres: morphometric analysis of four cases.

Authors:  P Giannakopoulos; P R Hof; C Bouras
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime.

Authors:  H Matsuda; A Yagishita; S Tsuji; K Hisada
Journal:  Eur J Nucl Med       Date:  1995-07
View more
  15 in total

1.  Prevalence and clinical characteristics of corticobasal syndrome with an initial symptom outside of the upper limb.

Authors:  Yuki Sakamoto; Toshio Shimizu; Shinsuke Tobisawa; Eiji Isozaki
Journal:  Neurol Sci       Date:  2017-02-11       Impact factor: 3.307

Review 2.  The corticobasal syndrome-Alzheimer's disease conundrum.

Authors:  Anhar Hassan; Jennifer L Whitwell; Keith A Josephs
Journal:  Expert Rev Neurother       Date:  2011-11       Impact factor: 4.618

3.  Clinicopathological correlations in corticobasal degeneration.

Authors:  Suzee E Lee; Gil D Rabinovici; Mary Catherine Mayo; Stephen M Wilson; William W Seeley; Stephen J DeArmond; Eric J Huang; John Q Trojanowski; Matthew E Growdon; Jung Y Jang; Manu Sidhu; Tricia M See; Anna M Karydas; Maria-Luisa Gorno-Tempini; Adam L Boxer; Michael W Weiner; Michael D Geschwind; Katherine P Rankin; Bruce L Miller
Journal:  Ann Neurol       Date:  2011-08       Impact factor: 10.422

Review 4.  Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.

Authors:  Keita Sakurai; Aya M Tokumaru; Keigo Shimoji; Shigeo Murayama; Kazutomi Kanemaru; Satoru Morimoto; Ikuko Aiba; Motoo Nakagawa; Yoshiyuki Ozawa; Masashi Shimohira; Noriyuki Matsukawa; Yoshio Hashizume; Yuta Shibamoto
Journal:  Neuroradiology       Date:  2017-04-06       Impact factor: 2.804

5.  Progressive Supranuclear Palsy and Corticobasal Degeneration.

Authors:  David G Coughlin; Dennis W Dickson; Keith A Josephs; Irene Litvan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Symmetric corticobasal degeneration (S-CBD).

Authors:  Anhar Hassan; Jennifer L Whitwell; Bradley F Boeve; Clifford R Jack; Joseph E Parisi; Dennis W Dickson; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2009-12-16       Impact factor: 4.891

Review 7.  Neurodegenerative dementia and parkinsonism.

Authors:  A Gabelle; F Portet; C Berr; J Touchon
Journal:  J Nutr Health Aging       Date:  2010-01       Impact factor: 4.075

8.  Corticobasal degeneration.

Authors:  Stephen G Reich; Stephen E Grill
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

9.  Structural and functional imaging in parkinsonian syndromes.

Authors:  Stephen M Broski; Christopher H Hunt; Geoffrey B Johnson; Robert F Morreale; Val J Lowe; Patrick J Peller
Journal:  Radiographics       Date:  2014 Sep-Oct       Impact factor: 5.333

10.  White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer's disease.

Authors:  Philippe Desmarais; Andrew F Gao; Julia Keith; Mario Masellis; Krista Lanctôt; Ekaterina Rogaeva; Joel Ramirez; Nathan Herrmann; Donald T Stuss; Sandra E Black
Journal:  Alzheimers Res Ther       Date:  2021-07-13       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.